Bacteria survive on any surface through the generation of biofilms that provide a protective
environment to grow as well as making them drug resistant. Extracellular polymeric matrix is …

Bacteriophage (phage) therapy, exploiting phages which are the natural enemies of
bacteria, has been re-introduced to treat multidrug-resistant (MDR) bacterial infections …

With the fast emergence of serious antibiotic resistance and the lagging discovery of novel
antibacterial drugs, phage therapy for pathogenic bacterial infections has acquired great …

Introduction The quest to combat bacterial infections has dreaded humankind for centuries.
Infections involving ESKAPE (Enterococcus spp., Staphylococcus aureus, Klebsiella …

The novel virulent Siphoviridae bacteriophage swi2 was isolated from a pig farm, and its
biological characteristics, genome architecture, and infection-related properties were …

The increasing global incidence of multidrug-resistant (MDR) bacterial infections threatens
public health and compromises various aspects of modern medicine. Recognising the …

Plasma‐based technology has been widely applied in the biomedicine, agriculture, and
environmental fields. In this study, a new application mode, namely plasma‐activated …

Pseudomonas aeruginosa (PA) is considered the first causal agent of morbidity and
mortality in people with cystic fibrosis (CF) disease. Multi-resistant strains have emerged due …

The increasing prevalence of multidrug resistant bacteria has warranted the search for new
antimicrobial agents as existing antibiotics lose their potency. Among these, bacteriophage …

The recent approval of experimental phage therapies by the FDA and other regulatory
bodies with expanded access in cases in the United States and other nations caught the …